ClinicalTrials.gov record
Completed Not applicable Interventional

pRESET for Occlusive Stroke Treatment

ClinicalTrials.gov ID: NCT03994822

Public ClinicalTrials.gov record NCT03994822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03994822
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
phenox Inc.
Industry
Enrollment
340 participants

Conditions and interventions

Interventions

  • Mechanical Thrombectomy using the Solitaire Revascularization Device Device
  • Mechanical Thrombectomy using the pRESET Thrombectomy device Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2019
Primary completion
May 11, 2022
Completion
May 11, 2022
Last update posted
Apr 20, 2023

2019 – 2022

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Honor Health Research Institute Scottsdale Arizona 85251
Providence Little Company of Mary Medical Center Santa Monica California 90404
University of Miami Coral Gables Florida 33146
Baptist Health Research Institute Jacksonville Jacksonville Florida 32207
Grady Memorial Hospital Atlanta Georgia 30322
Rush University Medical Center Chicago Illinois 60612
Advocate Lutheran General Hospital Downers Grove Illinois 60515
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Massachusetts Worcester Massachusetts 01655
JFK Medical Center Edison New Jersey 08820
Buffalo General Medical Center Buffalo New York 14203
NYU Langone Health New York New York 10016
The Mount Sinai Hosptial New York New York 10029
Montefiore Medical Center The Bronx New York 10467
OhioHealth Research Institute Columbus Ohio 43214
Oregon Health & Science University Portland Oregon 97239
UPMC Pittsburgh Pennsylvania 15213
Valley Baptist Harlingen Texas 78550
Swedish Medical Center - Cherry Hill Campus Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03994822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03994822 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →